Zent Clive S, Kay Neil E
Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
Clin Adv Hematol Oncol. 2004 Feb;2(2):107-13.
Monoclonal antibodies are an evolving treatment modality in chronic lymphocytic leukemia that has the potential to provide more effective and safer targeted therapy. This review provides historical context and detailed analysis of current developments, as well as an outline for future prospects and expectations in this exciting new arena of therapeutics.
单克隆抗体是慢性淋巴细胞白血病中一种不断发展的治疗方式，有潜力提供更有效、更安全的靶向治疗。本文献综述提供了历史背景以及对当前进展的详细分析，还概述了这一令人兴奋的新治疗领域的未来前景与期望。
